Clinical Trials Logo

Clinical Trial Summary

The main purpose of this study is to assess whether early integration of palliative and supportive care services in care of patients hospitalized for hematopoietic stem cell transplantation (HSCT) can improve patients' and family caregivers' quality of life and mood.


Clinical Trial Description

This research study is evaluating the impact of early involvement of supportive care team working with the transplant oncology team will have on the quality of life, symptoms, and mood of patients undergoing stem cell transplantation.

The purpose of this research study is to find out whether introducing patients and families undergoing stem cell transplantation to the palliative care team that specializes in symptom management can improve the physical and psychological symptoms that patients and families experience during hospitalization for stem cell transplantation.

The study will use a series of questionnaires to measure participant's and their caregivers' quality of life, physical symptoms, and mood. Study questionnaires will be completed in the hospital or clinic with assistance provided as needed ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02207322
Study type Interventional
Source Massachusetts General Hospital
Contact
Status Completed
Phase N/A
Start date August 2014
Completion date August 2017

See also
  Status Clinical Trial Phase
Terminated NCT02514733 - Association of Donor Age With Recipient Outcomes in Kidney Transplant
Completed NCT02014103 - Conversion From Brand to Generic Tacrolimus in High Risk Transplant Recipients Phase 4
Completed NCT02068872 - Gastric Sleeve Pilot Study in Morbidly Obese Undergoing Liver Transplantation Phase 1
Active, not recruiting NCT02843321 - Combined Infusion of Cytotoxic T-Lymphocytes and Vaccination Phase 1
Completed NCT02800811 - Safety, Tolerability, PK, PD, and Immunogenicity of Single and Multiple Ascending Intravenous Doses of FR104 Phase 1